Investing Profile

Jan Garfinkle

Photo of Jan Garfinkle, Managing Director at Arboretum Ventures
University of California, Berkeley Network
251 CONNECTIONS
The Wharton School Network
108 CONNECTIONS
Procter & Gamble Network
22 CONNECTIONS
cb
Arboretum Ventures Managing Director
$10.0M - $15.0M
$10.0M
23
$250M
CompanyStageDateRound SizeTotal Raised
AtaCor Medical
Series CApr 2024$28M
$53M
Co-investors: Jeff Terrell (Hatteras Venture Partners), Maria Berkman (Broadview Ventures)
Reprieve Cardiovascular
Series AFeb 2024$42M
$42M
Koya Medical
Series BFeb 2022$26M
Series AJan 2021$11M
$70M
Co-investors: Matthew Rizzo (OrbiMed), Eric Kwan (Locus Ventures)
Francis Medical
Series BSep 2021$55M
$55M
Co-investors: David Adair (Solas BioVentures)
RareCyte
Series GSep 2021$24M
$76M
Co-investors: Brian Daniels (5am Ventures), Robert Weisskoff (F-Prime Capital Partners), Robert Shepler (Telegraph Hill Partners), David Kabakoff (HealthQuest Capital)
BAROnova
Series CFeb 2013$27M
Series CFeb 2013$27M
Series BOct 2008$8M
Series BOct 2008$7.5M
Series AJan 2006$7M
Series AJan 2006$6.5M
$120M
Co-investors: Kevin Lalande (Santé Ventures)
Uptake Medical
Series CMar 2012$40M
Series CMar 2012$40M
Series BJul 2010$18M
Series BJul 2010$18M
Series AMay 2006$9M
$120M
Co-investors: Eric Kim (Goodwater Capital)
NxThera
Series BOct 2011$22M
Series BOct 2011$22M
$44M
Co-investors: Ben Shyong (Perseverance Capital)
Managing Partner, Founder Arboretum Ventures2002 - Present
President Strategic Marketing Consultants1995 - 2002
Director of Marketing and Clinical Research Devices for Vascular Intervention/Guidant1990 - 1995
Product Manager/Sales Representative Advanced Cardiovascular Systems/Guidant1984 - 1990
Manufacturing Manager/Process Engineer Procter & Gamble1979 - 1982
The Wharton School Master of Business Administration - MBA
University of California, Berkeley BSE Bioengineering